Business Context and Reporting Period
Company: LeMaitre Vascular, Inc. (LMAT)
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2025
Reporting Period: Preliminary results for the quarter ended December 31, 2024.
This filing serves as a notification that the Company issued a press release regarding its preliminary financial and operational results for the fourth quarter of 2024. The detailed financial data is contained in Exhibit 99.1 (the press release), which is furnished but not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1), the content of which is not included in the input text.
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
No specific material changes versus the prior comparable period are detailed in this document. The filing indicates that the Company has released preliminary results for the quarter ended December 31, 2024, but does not summarize the variances or trends within this text.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing includes a standard disclaimer regarding forward-looking statements. These statements are based on management's current, preliminary expectations and are subject to risks and uncertainties that could cause actual results to differ materially.
Risks: The document references risks and uncertainties included under the "Risk Factors" heading in the Company's most recent Annual Report on Form 10-K and subsequent filings. It explicitly states that undue reliance should not be placed on forward-looking statements.
Outlook: No specific guidance or outlook figures are provided in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and EPS figures for the quarter ended December 31, 2024.
- Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check the Company's most recent Form 10-K for detailed risk factors referenced in this filing.
- Confirm if the preliminary results include any restatements or unusual items affecting comparability.